15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 3 firms covering MacroGenics Inc, 2 rate it Buy or better, 1 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. The target range is very wide, $2.00 to $11.00 (about 5.5x), which points to deep disagreement over how to value the company rather than near-term timing. The average target of $6.33 sits 47% above the current $4.31. The rating mix has stayed broadly stable, with Buy-side ratings easing from 3 to 2 over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.35 next quarter toward $-1.47 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS3 ratings
Moderate Buy
Strong Buy00%
Buy267%
Hold133%
Sell00%
Strong Sell00%
Based on 3 analysts giving stock ratings to MacroGenics Inc.
As of Sep, 2 of 3 firms rate MGNX a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
MGNX EPS & revenue forecast
EPS · NEXT QUARTER
$-0.35
Range $-0.35 – $-0.35 · 1 analysts · +57% YoY
Next period, 1 analysts expect MacroGenics Inc to earn $-0.35 a share (range $-0.35 – $-0.35), versus $-0.22 a year earlier. Full-year consensus is $-1.56, growing to $-1.47 the year after.
REVENUE · NEXT QUARTER
$19.9M
Range $1.5M – $32.7M · 1 analysts · -52% YoY
Revenue is expected to reach $19.9M (range $1.5M – $32.7M), -51.8% year-over-year. Full-year consensus is $108.2M, rising to $90.6M next year.
Top analysts covering MacroGenics Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on MGNX.
#1
Silvan Tuerkcan
JMP Securities · Rank #26
Hold
No targeton MGNX
Overall win rate
53%
+ Follow
#2
Mayank Mamtani
B. Riley Securities · Rank #41
Buy
$11.00+155.2% to target
Overall win rate
50%
+ Follow
#3
RB
Robert Burns
HC Wainwright & Co. · Rank #199
Hold
No targeton MGNX
Overall win rate
41%
+ Follow
#4
SW
Stephen Willey
Stifel · Rank #345
Hold
$5.00+16.0% to target
Overall win rate
31%
+ Follow
#5
Etzer Darout
Barclays
Buy
$6.00+39.2% to target
Coverage
—
+ Follow
MGNX stock forecast FAQ
What is MGNX's average 12-month price target?+
The 3 analysts with a live target average $6.33 for MacroGenics Inc over the next 12 months, ranging from a $11.00 high to a $2.00 low.
Is MGNX stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 3 analyst ratings, 2 are Buy or Strong Buy, 1 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for MGNX?+
The Street-high target is $11.00 (B. Riley Securities), and the Street-low is $2.00 (HC Wainwright & Co.). The average of all 3 active targets is $6.33.
How many Wall Street analysts cover MGNX?+
3 analysts have an active rating on MacroGenics Inc, and 3 firms carry a live 12-month price target.
Who is the most accurate analyst covering MGNX?+
Among analysts who currently cover MGNX, Silvan Tuerkcan of JMP Securities has the strongest overall Quantellect track record (Rank #26). Their current call is Hold.
What is MacroGenics Inc's projected EPS for next quarter?+
The consensus estimate is $-0.35 per share (range $-0.35 – $-0.35) across 1 analysts. Full-year EPS is projected at $-1.56, rising to $-1.47 the following year.
How much revenue is MacroGenics Inc expected to report next quarter?+
Consensus revenue is $19.9M (range $1.5M – $32.7M). Full-year revenue is projected at $108.2M, growing to $90.6M next year.
Have analysts been upgrading or downgrading MGNX lately?+
As of Sep, 2 of 3 firms rate MGNX a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their MGNX calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
